Redox status evaluation in dogs affected by mast cell tumour

Veterinary and Comparative Oncology

Volumn 12, Issue 2, 2014, Pages 120-129

  Finotello, R ^a,b   Pasquini, A ^a   Meucci, V ^a   Lippi, I ^a   Rota, A ^a   Guidi, G ^a   Marchetti, V ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

BAP; D ROMs; Dog; Mast cell tumours; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ANIMAL; DOG; DOG DISEASE; FEMALE; MALE; MASTOCYTOMA; METABOLISM; OXIDATION REDUCTION REACTION; VETERINARY;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; DOG DISEASES; DOGS; FEMALE; MALE; MASTOCYTOMA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84897957735     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2012.00343.x     Document Type: Article

References (47)

1. Feig DI, Reid TM and Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Research 1994; 54: 1890-1894.
2. Dizdaroglu M, Jaruga P, Birincioglu M and Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radical Biology & Medicine 2002; 32: 1102-1115.
3. Breimer LH. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Molecular Carcinogenesis 1990; 3: 188-197.
4. Ye F, Zhou F, Bedolla RG, Jones T, Lei X, Kang T, Guadalupe M, Gao SJ. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathogens 2011; 7: e1002054.
5. Laviano A, Meguid MM, Preziosa I and Fanelli FR. Oxidative stress and wasting in cancer. Current Opinion in Clinical Nutrition & Metabolic Care 2007; 10: 449-456.
6. Maulik N and Das DK. Redox signaling in vascular angiogenesis. Free Radical Biology and Medicine 2002; 33: 1047-1060.
7. Katsabeki-Katsafli A, Kerenidi T, Kostikas K, Dalaveris E, Kiropoulos TS, Gogou E, Papaioannou AI and Gourgoulianis KI. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 2008; 60: 271-276.
8. Khodr B and Khalil Z. Modulation of inflammation by reactive oxygen species: implications for aging and tissue repair. Free Radical Biology & Medicine 2001; 30: 1-8.
9. Mates JM, Perez-Gomez C and De Castro IN. Antioxidant enzymes and human diseases. Clinical Biochemistry 1999; 32: 595-603.
10. McCall MR and Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radical Biology & Medicine 1999; 26: 1034-1053.
11. Sczubial M, Kankofer M, Loposzynski W, Dabrowski R and Lipko J. Oxidative stress parameters in bitches with mammary gland tumours. Journal of Veterinary Medicine A 2004; 51: 336-340.
12. Kumaraguruparan R, Balachandran C, Murali Manohar B and Nagini S. Altered oxidant-antioxidant profile in canine mammary tumours. Veterinary Research Communications 2005; 29: 287-296.
13. Vajdovich P, Kriska T, Mezes M, Szabo PR, Balogh N, Banfi A, Arany-Toth A, Gaal T and Jakus J. Redox status of dogs with non-hodgkin lymphomas. An ESR study. Cancer Letters 2005; 224: 339-346.
14. Winter JL, Barber LG, Freeman L, Griessmayr PC, Milbury PE and Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma. Journal of Veterinary Internal Medicine 2009; 23: 311-316.
15. Owen LN (Ed). World Health Organization TNM Classification of Tumors in Domestic Animals. Geneva, WHO, 1980.
16. Patnaik AK, Ehler WJ and MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984; 21: 469-474.
17. Pasquini A, Luchetti E, Marchetti V, Cardini G and Iorio EL. Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs. Veterinary Research Communications 2008; 32: 137-143.
18. Alberti A, Bolognini L, Macciantelli D and Carratelli M. The radical cation of N, N-diethylpara-phenylendiamine: a possible indicator of oxidative stress in biological samples. Research of Chemical Intermediate 2000; 26: 253-67.
19. Benzie IFF and Strain JJ. The ferric redicing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical Biochemistry 1996; 239: 70-76.
20. Piercy RJ, Hinchcliff KW, Morley PS, Disilvestro RA, Reinhart GA, Nelson SL, Schmidt KE and Morrie Craig A. Association between vitamin E and enhanced athletic performance in sled dogs. Medicine and Science in Sports and Exercise 2001; 33: 826-833.
21. McLellan GJ, Elks R, Lybaert P, Watté C, Moore DL and Bedford PG. Vitamin E deficiency in dogs with retinal pigment epithelial dystrophy. The Veterinary Record 2002; 151: 663-667.
22. Galler A, Tran JL, Krammer-Lukas S, Höller U, Thalhammer JG, Zentek J, Willmann M. Blood vitamin levels in dogs with chronic kidney disease. The Veterinary Journal 2012; 192: 226-231.
23. Trotti R, Carratelli M and Barbieri M. Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Medica 2002; 44: 37-40.
24. Vassalle C, Boni C, Di Cecco P, Ndreu R and Zucchelli GC. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clinical Chemistry and Laboratory Medicine 2006; 44: 1372-1375.
25. Freeman LM, Brown DJ and Rush JE. Assessment of degree of oxidative stress and antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy. Journal of the American Veterinary Medical Association 1999; 215: 644-646.
26. Freeman LM, Rush JE, Milbury PE and Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. Journal of Veterinary Internal Medicine 2005; 19: 537-541.
27. Walker T, Chan DL, Freeman LM, Milbury PE and Blumberg JB. Serial determination of biomarkers of oxidative stress and antioxidant status in dogs with naturally occurring gastric dilatation-volvulus. Journal of Veterinary Emergency and Critical Care 2007; 17: 250-256.
28. Pasquini A, Luchetti E and Cardini G. Evaluation of oxidative stress in hunting dogs during exercise. Research in Veterinary Science 2010; 89: 120-123.
29. McMichael MA. Oxidative stress, antioxidants, and assessment of oxidative stress in dog and cats. Journal of the American Veterinary Medical Association 2007; 231: 714-720.
30. Dohi K, Satoh K, Ohtaki H, Shioda S, Miyake Y, Shindo M and Aruga T. Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo 2005; 19: 855-860.
31. Hetyey CS, Manczur F, Dudás-Györki Z, Reiczigel J, Ribiczey P, Vajdovich P and Vörös K. Plasma antioxidant capacity in dogs with naturally occurring heart diseases. Journal of Veterinary Medicine A 2007; 54: 36-39.
32. Halliwell B. Antioxidants in human health and disease. Annual Review of Nutrition 1996; 16: 33-50.
33. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 2006; 39: 44-84.
34. Brooks AC, Whelan CJ and Purcell WM. Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition. British Journal of Pharmacology 1999; 128: 585-590.
35. Tsinkalovsky OR and Laerum OD. Flow cytometric measurement of the production of reactive oxygen intermediates in activated rat mast cells. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1994; 102: 474-480.
36. Gushchin IS and Tsinkalovsky OR. Dissociation of histamine secretion and changes of oxidant-antioxidant system indices in immunologically and nonimmunologically activated rat mast cells. Agents & Actions 1992; 30: 85-88.
37. Nakano N, Nakano A, Uchida T, Shirasaka N, Yoshizumi H, Okumura K, Tsuboi R and Ogawa H. Effect of arachidonic acid analogs on FceRI-mediated activation of mast cells. Biochimica et Biophysica Acta 2005; 1738: 19-28.
38. Vlahopoulos S, Boldogh I, Casola A and Brasier AR. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999; 94: 1878-1889.
39. Swindle EJ, Metcalfe DD and Coleman JW. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. Journal of Biological Chemistry 2004; 279: 48751-48759.
40. García G, Brazís P, Majó N, Ferrer L, de Mora F and Puigdemont A. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Veterinary Immunology & Immunopathology 1998; 62: 323-337.
41. Brigelius-Flohé R and Traber MG. Vitamin E: function and metabolism. The FASEB Journal 1999; 13: 1145-1155.
42. Jeziorska M, McCollum C and Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. Journal of Pathology 1997; 182: 115-122.
43. Gueck T, Aschenbach JR and Fuhrmann H. Influence of vitamin E on mast cell mediator release. Veterinary Dermatology 2002; 13: 301-305.
44. Kempná P, Reiter E, Arock M, Azzi A and Zingg JM. Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. Journal of Biological Chemistry 2004; 279: 50700-50709.
45. Thamm DH and Vail DM. Mast cell tumours. In: Withrow & MacEwen's Small Animal Oncology. 4edn, SJ Withrow and DM Vail Eds., Philadelphia, Sauders, 2007: 402-424.
46. Brigelius-Flohé R. Vitamin E: the shrew waiting to be tamed. Free Radical Biology & Medicine 2009; 46: 543-554.
47. Cutler RG, Plummer J, Chowdhury K and Heward C. Oxidative stress profiling: part II. Theory, technology, and practice. The New York Academy of Sciences 2005; 1055: 136-158.